OBJECTIVES: To determine the community seropositivity of pandemic (H1N1) 2009 influenza in order to estimate immunity and the community attack rate. METHODS: Selected clusters of participants (n=706) in the 'Victorian Health Monitor' (VHM), from whom blood samples were taken between August and October 2009, were tested opportunistically for antibodies to pandemic (H1N1) 2009 influenza virus. A titre of > or = 1:40 was chosen as the cut-off for recording seropositivity. The proportion (95% CI) of seropositive participants, aged 18 to <65 years of age, were computed for groups of census collection districts (CDs) across metropolitan Melbourne. RESULTS: The observed pandemic (H1N1) 2009 seropositivity rates for all CDs tested in metropolitan Melbourne was 16.0% (95% CI:12.9-19.1%); in northern Melbourne subset was 14.4% (95% CI:12.4-16.3%); and in eastern subset was 16.2% (95% CI:9.7-22.6%). The pre-pandemic (H1N1) 2009 positivity rate was estimated at 6%. CONCLUSION: Given this study's estimate of 16.0% seropositivity in adults in metropolitan Melbourne, and given the WHO laboratory's estimate of 6% pre-pandemic positivity, the estimated adult community attack rate was 10% for metropolitan Melbourne. IMPLICATIONS: This community attack rate is lower than anticipated and suggests that levels of immunity to Pandemic (H1N1) 2009 might be lower than anticipated. Although limited by a low response rate of 34%, this study suggests low adult seropositivity, which may be useful for public health professionals when encouraging the community to get vaccinated.
OBJECTIVES: To determine the community seropositivity of pandemic (H1N1) 2009 influenza in order to estimate immunity and the community attack rate. METHODS: Selected clusters of participants (n=706) in the 'Victorian Health Monitor' (VHM), from whom blood samples were taken between August and October 2009, were tested opportunistically for antibodies to pandemic (H1N1) 2009 influenza virus. A titre of > or = 1:40 was chosen as the cut-off for recording seropositivity. The proportion (95% CI) of seropositive participants, aged 18 to <65 years of age, were computed for groups of census collection districts (CDs) across metropolitan Melbourne. RESULTS: The observed pandemic (H1N1) 2009 seropositivity rates for all CDs tested in metropolitan Melbourne was 16.0% (95% CI:12.9-19.1%); in northern Melbourne subset was 14.4% (95% CI:12.4-16.3%); and in eastern subset was 16.2% (95% CI:9.7-22.6%). The pre-pandemic (H1N1) 2009 positivity rate was estimated at 6%. CONCLUSION: Given this study's estimate of 16.0% seropositivity in adults in metropolitan Melbourne, and given the WHO laboratory's estimate of 6% pre-pandemic positivity, the estimated adult community attack rate was 10% for metropolitan Melbourne. IMPLICATIONS: This community attack rate is lower than anticipated and suggests that levels of immunity to Pandemic (H1N1) 2009 might be lower than anticipated. Although limited by a low response rate of 34%, this study suggests low adult seropositivity, which may be useful for public health professionals when encouraging the community to get vaccinated.
Authors: Anna J X Zhang; Kelvin K W To; Herman Tse; Kwok-Hung Chan; Kun-Yuan Guo; Can Li; Ivan F N Hung; Jasper F W Chan; Honglin Chen; Sidney Tam; Kwok-Yung Yuen Journal: Clin Vaccine Immunol Date: 2011-09-07
Authors: Don Bandaranayake; Q Sue Huang; Ange Bissielo; Tim Wood; Graham Mackereth; Michael G Baker; Richard Beasley; Stewart Reid; Sally Roberts; Virginia Hope Journal: PLoS One Date: 2010-10-14 Impact factor: 3.240
Authors: Steven Riley; Kin O Kwok; Kendra M Wu; Danny Y Ning; Benjamin J Cowling; Joseph T Wu; Lai-Ming Ho; Thomas Tsang; Su-Vui Lo; Daniel K W Chu; Edward S K Ma; J S Malik Peiris Journal: PLoS Med Date: 2011-06-21 Impact factor: 11.069
Authors: Vernon J Lee; Mark I Chen; Jonathan Yap; Jocelyn Ong; Wei-Yen Lim; Raymond T P Lin; Ian Barr; Jimmy B S Ong; Tze Minn Mak; Lee Gan Goh; Yee Sin Leo; Paul M Kelly; Alex R Cook Journal: Am J Epidemiol Date: 2011-06-30 Impact factor: 4.897
Authors: Chad M Cox; Kate Goodin; Emily Fisher; Fatimah S Dawood; Janet J Hamilton; German F Leparc; Monica Gray; Linda Nelson; Rebekah H Borse; James A Singleton; Carrie Reed; Amanda L Balish; Jacqueline M Katz; Richard S Hopkins; Alicia M Fry Journal: PLoS One Date: 2011-12-20 Impact factor: 3.240
Authors: Caroline Marshall; Anne Kelso; Emma McBryde; Ian G Barr; Damon P Eisen; Joe Sasadeusz; Kirsty Buising; Allen C Cheng; Paul Johnson; Michael Richards Journal: Emerg Infect Dis Date: 2011-06 Impact factor: 6.883
Authors: James M Trauer; Don Bandaranayake; Robert Booy; Mark I Chen; Michelle Cretikos; Gary K Dowse; Dominic E Dwyer; Michael E Greenberg; Q Sue Huang; Gulam Khandaker; Jen Kok; Karen L Laurie; Vernon J Lee; Jodie McVernon; Scott Walter; Peter G Markey Journal: Emerg Infect Dis Date: 2013-01 Impact factor: 6.883